Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range
Authors:
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 51 (3) , 626-632
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Development, Validation, and Clinical Implementation of an Assay to Measure Total Antibody Response to Naglazyme® (Galsulfase)The AAPS Journal, 2008
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- Development, validation and application of a chemiluminescent immunoassay for the measurement of circulating chorionic gonadotropin levels in the laboratory macaqueJournal of Medical Primatology, 2006
- Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteersClinical Pharmacology & Therapeutics, 2006
- Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal AntibodiesClinical Chemistry, 2005
- A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serumJournal of Pharmaceutical and Biomedical Analysis, 2005
- Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sportJournal of Pharmaceutical and Biomedical Analysis, 2004
- Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of MacromoleculesPharmaceutical Research, 2003
- A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxyl-terminal B-chain analogues of human insulinJournal of Pharmaceutical and Biomedical Analysis, 2001
- Validation of immunoassays for bioanalysis: a pharmaceutical industry perspectiveJournal of Pharmaceutical and Biomedical Analysis, 2000